Supernus Pharmaceuticals | Ativos



Assets Alterar Data
Abbott USD 84B 2.55B 2025-06
ANI Pharmaceuticals USD 1.34B 50.57M 2025-06
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 801.72M 44.73M 2025-06
Eisai JPY 1.41T 23.07B 2025-06
Eli Lilly USD 100.92B 11.53B 2025-06
Novo Nordisk 482.15B 7.01B 2025-06
Pacira USD 1.54B 49.41M 2025-06
Perrigo USD 10.09B 334.3M 2025-06
Pfizer USD 206.1B 1.93B 2025-06
Supernus Pharmaceuticals USD 1.38B 35.11M 2025-06
United Therapeutics USD 7.91B 164.1M 2025-06
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12


Supernus Pharmaceuticals Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.